A retrospective analysis of the change in anti-malarial treatment policy: Peru

被引:18
|
作者
Williams, Holly Ann [1 ,5 ]
Vincent-Mark, Arlene [2 ,5 ]
Herrera, Yenni [3 ]
Chang, O. Jaime [4 ]
机构
[1] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30341 USA
[2] CDC, Div Injury Response, Atlanta, GA 30333 USA
[3] Minist Salud, Jesus Maria Lima, Peru
[4] USAID, Lima, Peru
[5] Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Atlanta, GA 30341 USA
关键词
MALARIA-TREATMENT POLICY; DRUG POLICY; SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE; LESSONS;
D O I
10.1186/1475-2875-8-85
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: National malaria control programmes must deal with the complex process of changing national malaria treatment guidelines, often without guidance on the process of change. Selecting a replacement drug is only one issue in this process. There is a paucity of literature describing successful malaria treatment policy changes to help guide control programs through this process. Objectives: To understand the wider context in which national malaria treatment guidelines were formulated in a specific country (Peru). Methods: Using qualitative methods (individual and focus group interviews, stakeholder analysis and a review of documents), a retrospective analysis of the process of change in Peru's anti-malarial treatment policy from the early 1990's to 2003 was completed. Results: The decision to change Peru's policies resulted from increasing levels of anti-malarial drug resistance, as well as complaints from providers that the drugs were no longer working. The context of the change occurred in a time in which Peru was changing national governments, which created extreme challenges in moving the change process forward. Peru utilized a number of key strategies successfully to ensure that policy change would occur. This included a) having the process directed by a group who shared a common interest in malaria and who had long-established social and professional networks among themselves, b) engaging in collaborative teamwork among nationals and between nationals and international collaborators, c) respect for and inclusion of district-level staff in all phases of the process, d) reliance on high levels of technical and scientific knowledge, e) use of standardized protocols to collect data, and f) transparency. Conclusion: Although not perfectly or fully implemented by 2003, the change in malaria treatment policy in Peru occurred very quickly, as compared to other countries. They identified a problem, collected the data necessary to justify the change, utilized political will to their favor, approved the policy, and moved to improve malaria control in their country. As such, they offer an excellent example for other countries as they contemplate or embark on policy changes.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] A retrospective analysis of the change in anti-malarial treatment policy: Peru
    Holly Ann Williams
    Arlene Vincent-Mark
    Yenni Herrera
    O Jaime Chang
    Malaria Journal, 8
  • [2] Partnership to improve the quality of evidence needed to change policy for anti-malarial treatment in West Africa: The example of the West Africa network for monitoring anti-malarial treatment It [MIM-WK-238650]
    Kazad, W.
    Guiguemde, R.
    Targett, G.
    Meek, S.
    Greenwood, B.
    ACTA TROPICA, 2005, 95 : S244 - S244
  • [3] Anti-malarial mosquitoes?
    Gareth J. Lycett
    Fotis C. Kafatos
    Nature, 2002, 417 : 387 - 388
  • [4] Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
    Tam, Dao Ngoc Hien
    Tawfik, Gehad Mohamed
    El-Qushayri, Amr Ehab
    Mehyar, Ghaleb Muhammad
    Istanbuly, Sedralmontaha
    Karimzadeh, Sedighe
    Tu, Vo Linh
    Tiwari, Ranjit
    Van Dat, Truong
    Nguyen, Phuong Thuy Viet
    Hirayama, Kenji
    Huy, Nguyen Tien
    MALARIA JOURNAL, 2020, 19 (01)
  • [5] Anti-malarial priorities
    Sampson, R. A. S.
    CHEMISTRY WORLD, 2007, 4 (09): : 40 - 40
  • [6] ANTI-MALARIAL DRUGS
    GARRY, D
    IRISH MEDICAL JOURNAL, 1985, 78 (10) : 299 - 299
  • [7] ANTI-MALARIAL DRUGS
    GAYRAL, P
    LYON PHARMACEUTIQUE, 1979, 30 (03): : 209 - 219
  • [8] Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
    Dao Ngoc Hien Tam
    Gehad Mohamed Tawfik
    Amr Ehab El-Qushayri
    Ghaleb Muhammad Mehyar
    Sedralmontaha Istanbuly
    Sedighe Karimzadeh
    Vo Linh Tu
    Ranjit Tiwari
    Truong Van Dat
    Phuong Thuy Viet Nguyen
    Kenji Hirayama
    Nguyen Tien Huy
    Malaria Journal, 19
  • [9] A protocol for monitoring treatment with synthetic anti-malarial drugs
    Leid, J
    Plantey, J
    Leid, V
    COLOUR VISION DEFICIENCIES XIII, 1997, 59 : 231 - 238
  • [10] ANTI-MALARIAL TREATMENT REGIMES FROM AN EVOLUTIONARY PERSPECTIVE
    Huijben, Silvie
    Sim, Derek
    Chan, Brian
    Tomasello, Danielle
    Read, Andrew
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 257 - 257